TLR-3/9 Agonists Synergize with Anti-ErbB2 mAb-Letter

Cancer Res. 2017 Jun 15;77(12):3376-3378. doi: 10.1158/0008-5472.CAN-17-0412. Epub 2017 Jun 5.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Humans
  • Receptor, ErbB-2
  • Toll-Like Receptors*
  • Trastuzumab*

Substances

  • Toll-Like Receptors
  • ERBB2 protein, human
  • Receptor, ErbB-2
  • Trastuzumab